Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of Atp7a RNA contributes to differentiation-dependent Cu redistribution in skeletal muscle cells. | Metallomics | 2023 | 37391383 | PubTator, text mining | PubMed |
| Long non-coding RNAs modulate tumor microenvironment to promote metastasis: novel avenue for therapeutic intervention. | Front Cell Dev Biol | 2023 | 37384249 | PubTator, text mining | PubMed |
| The Link between Diabetes, Pancreatic Tumors, and miRNAs-New Players for Diagnosis and Therapy? | Int J Mol Sci | 2023 | 37373398 | PubTator, text mining | PubMed |
| Uncovering the Secrets of Prostate Cancer's Radiotherapy Resistance: Advances in Mechanism Research. | Biomedicines | 2023 | 37371723 | PubTator, text mining | PubMed |
| Ez-Metastasizing: The Crucial Roles of Ezrin in Metastasis. | Cells | 2023 | 37371090 | PubTator, text mining | PubMed |
| Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinoma. | Front Genet | 2023 | 37351348 | PubTator, text mining | PubMed |
| Weaving the nest: extracellular matrix roles in pre-metastatic niche formation. | Front Oncol | 2023 | 37350937 | PubTator, text mining | PubMed |
| Mechanisms of portal vein tumour thrombus formation and development in patients with hepatocellular carcinoma. | J Cell Mol Med | 2023 | 37349905 | PubTator, text mining | PubMed |
| Apoptosis-targeted gene therapy for non-small cell lung cancer using chitosan-poly-lactic-co-glycolic acid -based nano-delivery system and CASP8 and miRs 29A-B1 and 34A. | Front Bioeng Biotechnol | 2023 | 37346791 | PubTator, text mining | PubMed |
| Homozygous LOXL2 variant in individuals affected by non-syndromic occipital encephalocele. | Birth Defects Res | 2023 | 37345575 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP/LOXL2 pathway. | J Nanobiotechnology | 2023 | 37328872 | PubTator, text mining | PubMed |
| Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis? | Front Immunol | 2023 | 37325634 | PubTator, text mining | PubMed |
| Identification of Three Cuproptosis-specific Expressed Genes as Diagnostic Biomarkers and Therapeutic Targets for Atherosclerosis. | Int J Med Sci | 2023 | 37324184 | PubTator, text mining | PubMed |
| New Functions of Intracellular LOXL2: Modulation of RNA-Binding Proteins. | Molecules | 2023 | 37298909 | PubTator, text mining | PubMed |
| VE-Cadherin in Cancer-Associated Angiogenesis: A Deceptive Strategy of Blood Vessel Formation. | Int J Mol Sci | 2023 | 37298296 | PubTator, text mining | PubMed |
| Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy. | Cancers (Basel) | 2023 | 37296972 | PubTator, text mining | PubMed |
| Significant improvement of bone marrow-derived MSC expansion from MDS patients by defined xeno-free medium. | Stem Cell Res Ther | 2023 | 37287056 | PubTator, text mining | PubMed |
| Copper homeostasis dysregulation promoting cell damage and the association with liver diseases. | Chin Med J (Engl) | 2023 | 37284739 | PubTator, text mining | PubMed |
| Irisin attenuates angiotensin II-induced atrial fibrillation and atrial fibrosis via LOXL2 and TGFβ1/Smad2/3 signaling pathways. | Iran J Basic Med Sci | 2023 | 37275755 | PubTator, text mining | PubMed |
| Perspectives on precision cut lung slices-powerful tools for investigation of mechanisms and therapeutic targets in lung diseases. | Front Pharmacol | 2023 | 37261291 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=19